Hyperlipoproteinemia Type V: Clinical Trials

1 trial for Hyperlipoproteinemia Type V, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow Hyperlipoproteinemia Type V: new trials by email Literature Review of Hyperlipoproteinemia Type V trials Research Report on Hyperlipoproteinemia Type V

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
MK0859 Dose-Ranging Study (0859-003)
MK0859 - Hypercholesterolemia, Mixed Hyperlipemia
Phase 2TerminatedMerck Sharp & Dohme LLC5002006-06-012015-03-02

Narrower conditions

Hypercholesterolemia (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Dyslipidemias (1)  ·  Genetic Diseases, Inborn (1)  ·  Hyperlipidemias (1)  ·  Hyperlipoproteinemias (1)  ·  Hypertriglyceridemia (1)  ·  Lipid Metabolism Disorders (1)  ·  Lipid Metabolism, Inborn Errors (1)  ·  Metabolic Diseases (1)  ·  Metabolism, Inborn Errors (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

anacetrapib (1)

Sponsors

Merck Sharp & Dohme LLC (1)

Results publications

PMID 21982664, PMID 25670366